{
    "clinical_study": {
        "@rank": "129261", 
        "acronym": "eMESH 1", 
        "arm_group": [
            {
                "arm_group_label": "eSVS Mesh treated saphenous vein graft", 
                "arm_group_type": "Active Comparator", 
                "description": "Each subject will be randomized to an eSVS Mesh treated SVG to the right or left coronary system."
            }, 
            {
                "arm_group_label": "Control saphenous vein graft", 
                "arm_group_type": "Sham Comparator", 
                "description": "Each subject will be randomized to an untreated (no eSVS Mesh) SVG to the right or left coronary system."
            }, 
            {
                "arm_group_label": "Single Vessel Treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "Each subject with receive one SVG with eSVS Mesh either to the right or left coronary system."
            }
        ], 
        "brief_summary": {
            "textblock": "Multi-center, dual cohort (randomized and single vessel) study designed to demonstrate\n      feasibility, initial safety and performance of the Kips Bay Medical, Inc. eSVS\u00ae Mesh as an\n      external vein support device for use over saphenous vein grafts during coronary artery\n      bypass surgery.  In the Randomized Cohort, each study subject will receive a SVG without\n      Mesh (control) and a SVG with the eSVS Mesh (treatment).  In the Single Vessel Cohort, each\n      study subject will receive one SVG with the eSVS Mesh."
        }, 
        "brief_title": "The eMESH 1 Feasibility Study", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)", 
        "condition_browse": {
            "mesh_term": "Atherosclerosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Randomized Cohort: Requires CABG surgery with a SVG to the right coronary artery\n             (RCA) system  AND the left circumflex artery (LCX) system with a \u2265 70% stenosis in\n             each of the two systems.\n\n          -  Single Vessel Cohort: Requires CABG surgery with a SVG to the RCA system or the LCX\n             system with a > 70% stenosis in the system.\n\n          -  Medial sternotomy with cardiopulmonary bypass (CPB) during surgery.\n\n          -  Both saphenous vein graft length are adequate for planned intervention, vein outer\n             diameter is between 3.6 mm and 7.0 mm and double wall thickness less than 1.4 mm.\n\n          -  Agreement to post-procedure follow-up contact and testing (including follow-up\n             coronary angiogram).\n\n        Exclusion Criteria:\n\n          -  Concomitant non-CABG cardiac procedure.\n\n          -  Prior cardiac surgery (does not include percutaneous procedures).\n\n          -  Cerebrovascular or transient ischemia attack within 30 days of the CABG procedure.\n\n          -  Age > 85 years.\n\n          -  Left ventricular ejection fraction \u2264 35%.\n\n          -  Creatinine > 133 \u03bcmol/L (1.5 mg/dL) prior to CABG procedure or on chronic dialysis.\n\n          -  STEMI within 7 days or total CK > 2 times the upper limit of normal prior to the CABG\n             procedure.\n\n          -  Both enrolled grafts will feed non-viable myocardial territory.\n\n          -  Diffuse atherosclerotic disease (> 70%) distal to either of the enrolled target\n             coronary arteries.\n\n          -  Randomized Cohort: By visual estimate, the target coronary artery diameter of both\n             the right coronary system and left circumflex system must be within 1.5mm of each\n             other.\n\n          -  Planned endarterectomy of the target coronary artery."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01676376", 
            "org_study_id": "11016"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "eSVS Mesh treated saphenous vein graft", 
                    "Single Vessel Treatment"
                ], 
                "description": "During coronary artery bypass graft surgery, one SVG will be randomized to be treated with eSVS Mesh and implanted in the right or left coronary system.", 
                "intervention_name": "eSVS Mesh treated saphenous vein graft", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Control saphenous vein graft", 
                "description": "During coronary artery bypass graft surgery, one SVG will be randomized to be the control (no eSVS Mesh) and implanted in the right or left coronary system.", 
                "intervention_name": "Control saphenous vein graft", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "CABG", 
            "SVG", 
            "nitinol mesh", 
            "external saphenous vein graft support"
        ], 
        "lastchanged_date": "February 27, 2014", 
        "link": {
            "description": "Sponsor website", 
            "url": "http://www.kipsbaymedical.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30308"
                    }, 
                    "name": "Emory University Hospital Midtown"
                }, 
                "investigator": {
                    "last_name": "John Puskas, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30501"
                    }, 
                    "name": "Northeast Georgia Heart Center"
                }, 
                "investigator": {
                    "last_name": "Alan Wolfe, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Mayo Clinic / St. Mary's Hospital"
                }, 
                "investigator": {
                    "last_name": "Lyle Joyce, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "St. Luke's Hospital / Texas Heart Institute"
                }, 
                "investigator": {
                    "last_name": "Ross Reul, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France"
                    }, 
                    "name": "C.H.U. Dupuytren"
                }, 
                "investigator": {
                    "last_name": "Marc Laskar, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France"
                    }, 
                    "name": "Bordeaux University Hospital"
                }, 
                "investigator": {
                    "last_name": "Louis Labrousse, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Massa", 
                        "country": "Italy"
                    }, 
                    "name": "Heart Hospital - G. Monasterio Tuscany Foundation for Health & Research"
                }, 
                "investigator": {
                    "last_name": "Mattias Glauber, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands"
                    }, 
                    "name": "Catharina Ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "Erwin Tan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "3010"
                    }, 
                    "name": "University Hospital of Bern"
                }, 
                "investigator": {
                    "last_name": "Lars Englberger, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW3 6NP"
                    }, 
                    "name": "Royal Brompton Hospital"
                }, 
                "investigator": {
                    "last_name": "Anthony DeSouza, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "France", 
                "Italy", 
                "Netherlands", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multi-center, International Study of External Saphenous Vein Support Using eSVS\u00ae Mesh in CABG Surgery: The eMESH I Study", 
        "overall_contact": {
            "email": "clinical@kipsbaymedical.com", 
            "last_name": "Rebecca Wetterling", 
            "phone": "763-235-3540"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Bern", 
                "last_name": "Lars Englberger, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Emory University", 
                "last_name": "John Puskas, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Switzerland: Swissmedic", 
                "United States: Food and Drug Administration", 
                "France: Institutional Ethical Committee", 
                "Italy: Ethics Committee", 
                "England: NHS Health Research Authority"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The rate of major adverse coronary events (MACE) defined as the rate of the composite of total mortality, MI (Q wave and non Q wave), and/or coronary target vessel revascularization (percutaneous coronary intervention or CABG).", 
                "measure": "MACE", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Angiographic patency rate of the enrolled grafts defined as < 50% stenosis.", 
                "measure": "SVG patency determined by angiography", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Technical success defined as successful placement of the eSVS Mesh on the saphenous vein and surgical implantation of the SVG.", 
                "measure": "Technical success implanting eSVS Mesh", 
                "safety_issue": "No", 
                "time_frame": "intra-operative"
            }
        ], 
        "removed_countries": {
            "country": "Germany"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01676376"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "MACE, MACCE, MI and all mortality rates through five years, mediastinitis rate through 6 months.", 
                "measure": "MACCE and mediastinitis", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Angiographic patency rate of the enrolled grafts defined as < 75%.", 
                "measure": "SVG patency determined by angiography", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Plaque burden  of the enrolled grafts as assessed by IVUS imaging (IVUS Sub-Study).", 
                "measure": "Plaque burden", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Kips Bay Medical, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kips Bay Medical, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}